NCT01595360View on ClinicalTrials.gov

Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Tooth Extraction
Interventions
DRUG

Placebo

It is applied directly to the bleeding site after tooth extraction

DRUG

TT-173

It is applied directly to the bleeding site after tooth extraction

Trial Locations (1)

08860

Thrombotargets Europe SL, Castelldefels

All Listed Sponsors
lead

Thrombotargets Europe S.L

INDUSTRY

NCT01595360 - Safety, Tolerability and Efficacy Study of TT-173 in Healthy Volunteers After Tooth Extraction | Biotech Hunter | Biotech Hunter